Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Dec ' 10 | Jun ' 10 | Dec ' 09 | Jun ' 09 | Dec ' 08 | |
|---|---|---|---|---|---|
| Sales | 160.22 | 136.69 | 130.80 | 115.71 | 103.55 |
| Operating profit | 35.24 | 40.13 | 32.77 | 28.86 | 24.90 |
| Interest | - | - | - | - | 0.01 |
| Gross profit | 37.37 | 41.68 | 34.27 | 29.70 | 26.28 |
| EPS (Rs) | 47.81 | 52.89 | 43.02 | 36.25 | 32.86 |
Half yearly
results in details
| Dec ' 10 | Jun ' 10 | Dec ' 09 | Jun ' 09 | Dec ' 08 | |
|---|---|---|---|---|---|
| Other income | 2.13 | 1.55 | 1.50 | 0.84 | 1.39 |
| Stock adjustment | 5.08 | -4.35 | 0.91 | 1.29 | -6.55 |
| Raw material | 25.76 | 28.71 | 27.06 | 22.73 | 25.39 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 19.26 | 14.47 | 14.20 | 12.27 | 10.74 |
| Excise | - | - | - | 3.36 | -7.14 |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 74.88 | 57.74 | 55.86 | 47.21 | 56.20 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.62 | 1.58 | 2.06 | 1.25 | 0.60 |
| Taxation | 11.61 | 13.39 | 10.48 | 10.15 | 9.08 |
| Net profit / loss | 24.14 | 26.71 | 21.73 | 18.30 | 16.59 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 5.63 | 5.63 | 15.73 | 15.73 | 15.73 |
| Agg.of non promotoholding (%) | 11.15 | 11.15 | 31.15 | 31.15 | 31.15 |
| OPM (%) | 21.99 | 29.36 | 25.06 | 24.94 | 24.05 |
| GPM (%) | 23.02 | 30.15 | 25.90 | 25.48 | 25.04 |
| NPM (%) | 14.87 | 19.32 | 16.42 | 15.70 | 15.81 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis